CONSHOHOCKEN, PA and VANCOUVER, BC – October 5, 2007 – Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs, is pleased to announce its President & CEO, Dr. Christopher Gallen, has been named a finalist for a 2007 Scrip Award in the category of “Executive of the Year.” Winners will be announced at the Scrip’s award ceremony in London, UK, on December 4th. For more information on this award visit: http://www.scripawards.com/
